Logo image of FRVIA.PA

FORVIA (FRVIA.PA) Stock Fundamental Analysis

Europe - EPA:FRVIA - FR0000121147 - Common Stock

11.55 EUR
+0.44 (+3.91%)
Last: 10/3/2025, 7:00:00 PM
Fundamental Rating

3

Overall FRVIA gets a fundamental rating of 3 out of 10. We evaluated FRVIA against 30 industry peers in the Automobile Components industry. Both the profitability and financial health of FRVIA have multiple concerns. A decent growth rate in combination with a cheap valuation! Better keep an eye on FRVIA.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year FRVIA was profitable.
FRVIA had a positive operating cash flow in the past year.
In the past 5 years FRVIA reported 4 times negative net income.
FRVIA had a positive operating cash flow in each of the past 5 years.
FRVIA.PA Yearly Net Income VS EBIT VS OCF VS FCFFRVIA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

With a Return On Assets value of -1.58%, FRVIA is not doing good in the industry: 63.33% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -12.49%, FRVIA is doing worse than 70.00% of the companies in the same industry.
FRVIA has a Return On Invested Capital (5.70%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for FRVIA is below the industry average of 6.88%.
The 3 year average ROIC (4.67%) for FRVIA is below the current ROIC(5.70%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.58%
ROE -12.49%
ROIC 5.7%
ROA(3y)-0.36%
ROA(5y)-0.69%
ROE(3y)-2.6%
ROE(5y)-4.25%
ROIC(3y)4.67%
ROIC(5y)4.19%
FRVIA.PA Yearly ROA, ROE, ROICFRVIA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

FRVIA has a Operating Margin of 4.73%. This is comparable to the rest of the industry: FRVIA outperforms 46.67% of its industry peers.
FRVIA's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 13.49%, FRVIA is doing worse than 83.33% of the companies in the same industry.
FRVIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.73%
PM (TTM) N/A
GM 13.49%
OM growth 3Y-1.94%
OM growth 5Y-8.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.47%
GM growth 5Y-0.92%
FRVIA.PA Yearly Profit, Operating, Gross MarginsFRVIA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so FRVIA is still creating some value.
The number of shares outstanding for FRVIA remains at a similar level compared to 1 year ago.
Compared to 5 years ago, FRVIA has more shares outstanding
FRVIA has a better debt/assets ratio than last year.
FRVIA.PA Yearly Shares OutstandingFRVIA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
FRVIA.PA Yearly Total Debt VS Total AssetsFRVIA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

FRVIA has an Altman-Z score of 1.19. This is a bad value and indicates that FRVIA is not financially healthy and even has some risk of bankruptcy.
FRVIA has a worse Altman-Z score (1.19) than 83.33% of its industry peers.
FRVIA has a debt to FCF ratio of 12.32. This is a negative value and a sign of low solvency as FRVIA would need 12.32 years to pay back of all of its debts.
The Debt to FCF ratio of FRVIA (12.32) is comparable to the rest of the industry.
FRVIA has a Debt/Equity ratio of 2.72. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.72, FRVIA is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.72
Debt/FCF 12.32
Altman-Z 1.19
ROIC/WACC1.02
WACC5.59%
FRVIA.PA Yearly LT Debt VS Equity VS FCFFRVIA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

FRVIA has a Current Ratio of 0.98. This is a bad value and indicates that FRVIA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.98, FRVIA is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
FRVIA has a Quick Ratio of 0.98. This is a bad value and indicates that FRVIA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.79, FRVIA is not doing good in the industry: 63.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.79
FRVIA.PA Yearly Current Assets VS Current LiabilitesFRVIA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

FRVIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 259.18%, which is quite impressive.
The earnings per share for FRVIA have been decreasing by -20.18% on average. This is quite bad
Looking at the last year, FRVIA shows a decrease in Revenue. The Revenue has decreased by -0.90% in the last year.
The Revenue has been growing by 8.71% on average over the past years. This is quite good.
EPS 1Y (TTM)259.18%
EPS 3YN/A
EPS 5Y-20.18%
EPS Q2Q%11300%
Revenue 1Y (TTM)-0.9%
Revenue growth 3Y19.98%
Revenue growth 5Y8.71%
Sales Q2Q%-0.42%

3.2 Future

The Earnings Per Share is expected to grow by 35.88% on average over the next years. This is a very strong growth
FRVIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.11% yearly.
EPS Next Y-85.96%
EPS Next 2Y37.42%
EPS Next 3Y35.88%
EPS Next 5YN/A
Revenue Next Year-2.33%
Revenue Next 2Y-0.33%
Revenue Next 3Y1.11%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
FRVIA.PA Yearly Revenue VS EstimatesFRVIA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B 25B
FRVIA.PA Yearly EPS VS EstimatesFRVIA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 3.28, which indicates a rather cheap valuation of FRVIA.
FRVIA's Price/Earnings ratio is rather cheap when compared to the industry. FRVIA is cheaper than 96.67% of the companies in the same industry.
FRVIA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.86.
A Price/Forward Earnings ratio of 4.85 indicates a rather cheap valuation of FRVIA.
93.33% of the companies in the same industry are more expensive than FRVIA, based on the Price/Forward Earnings ratio.
FRVIA is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.28
Fwd PE 4.85
FRVIA.PA Price Earnings VS Forward Price EarningsFRVIA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FRVIA indicates a somewhat cheap valuation: FRVIA is cheaper than 80.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FRVIA indicates a rather cheap valuation: FRVIA is cheaper than 96.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.61
EV/EBITDA 2.4
FRVIA.PA Per share dataFRVIA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

FRVIA's earnings are expected to grow with 35.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.42%
EPS Next 3Y35.88%

0

5. Dividend

5.1 Amount

No dividends for FRVIA!.
Industry RankSector Rank
Dividend Yield N/A

FORVIA

EPA:FRVIA (10/3/2025, 7:00:00 PM)

11.55

+0.44 (+3.91%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-28 2025-07-28/dmh
Earnings (Next)10-20 2025-10-20
Inst Owners33.83%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap2.28B
Analysts72.17
Price Target13.88 (20.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.5
Dividend Growth(5Y)-15.05%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.24%
PT rev (3m)21.45%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)65.81%
EPS NY rev (3m)-93.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.1%
Valuation
Industry RankSector Rank
PE 3.28
Fwd PE 4.85
P/S 0.08
P/FCF 2.61
P/OCF 0.86
P/B 0.62
P/tB N/A
EV/EBITDA 2.4
EPS(TTM)3.52
EY30.48%
EPS(NY)2.38
Fwd EY20.6%
FCF(TTM)4.43
FCFY38.34%
OCF(TTM)13.46
OCFY116.52%
SpS136.57
BVpS18.64
TBVpS-29.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.58%
ROE -12.49%
ROCE 8.01%
ROIC 5.7%
ROICexc 7.8%
ROICexgc 36.54%
OM 4.73%
PM (TTM) N/A
GM 13.49%
FCFM 3.24%
ROA(3y)-0.36%
ROA(5y)-0.69%
ROE(3y)-2.6%
ROE(5y)-4.25%
ROIC(3y)4.67%
ROIC(5y)4.19%
ROICexc(3y)6.19%
ROICexc(5y)5.9%
ROICexgc(3y)22.61%
ROICexgc(5y)20.29%
ROCE(3y)6.59%
ROCE(5y)6%
ROICexcg growth 3Y4.68%
ROICexcg growth 5Y-6.21%
ROICexc growth 3Y-2.68%
ROICexc growth 5Y-11.4%
OM growth 3Y-1.94%
OM growth 5Y-8.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.47%
GM growth 5Y-0.92%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 2.72
Debt/FCF 12.32
Debt/EBITDA 3
Cap/Depr 86.4%
Cap/Sales 6.61%
Interest Coverage 250
Cash Conversion 79.6%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.79
Altman-Z 1.19
F-Score4
WACC5.59%
ROIC/WACC1.02
Cap/Depr(3y)110.58%
Cap/Depr(5y)102.8%
Cap/Sales(3y)7.99%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)259.18%
EPS 3YN/A
EPS 5Y-20.18%
EPS Q2Q%11300%
EPS Next Y-85.96%
EPS Next 2Y37.42%
EPS Next 3Y35.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.9%
Revenue growth 3Y19.98%
Revenue growth 5Y8.71%
Sales Q2Q%-0.42%
Revenue Next Year-2.33%
Revenue Next 2Y-0.33%
Revenue Next 3Y1.11%
Revenue Next 5YN/A
EBIT growth 1Y-1.49%
EBIT growth 3Y17.66%
EBIT growth 5Y0%
EBIT Next Year181.01%
EBIT Next 3Y46.93%
EBIT Next 5YN/A
FCF growth 1Y57.44%
FCF growth 3Y46.28%
FCF growth 5Y8.26%
OCF growth 1Y0.97%
OCF growth 3Y23.48%
OCF growth 5Y8.09%